Why was Visine taken off the shelves?
Visine itself has not been pulled from shelves as a brand, but a specific product line, Visine LR (Long Lasting Redness Relief), was quietly discontinued by LR Johnson & Johnson, and separately, eye care professionals have raised serious safety concerns about Visine's core ingredient that make it worth understanding before you reach for a bottle.
Here's the answer from Mary's digital twin. The gray check mark turns green once Mary has confirmed it.
What actually happened with Visine LR
Johnson & Johnson discontinued Visine LR, the long-lasting redness relief formula with oxymetazoline as its main ingredient. The company's stated reason was slow sales, though many loyal users pushed back hard on that explanation, arguing nothing else on the market worked the same way for them.
The safety concern with standard Visine
The broader worry is about the main ingredient in classic Visine, not a recall but a medical opinion that has gained ground. Visine, introduced in 1954, contains tetrahydrozoline hydrochloride, which may relieve eye redness temporarily, but its side effects include slow heart rate, disruption of breathing, and other serious effects, leading some eye care clinics to say they would not recommend it and that it would not be FDA approved today. The "get the red out" effect is real but short lived, and it comes with a rebound: your eyes often get redder after the drops wear off, pulling you back to the bottle.
The wider wave of eye drop recalls
It is also worth knowing that the eye drop category broadly has been under significant scrutiny. In March 2026, K.C. Pharmaceuticals voluntarily recalled more than 3 million bottles of eye drops due to a "lack of assurance of sterility," meaning the company could not guarantee the products were free from harmful bacteria or fungi. In 2023, recalled eye drops were associated with four deaths, 14 cases of vision loss, and 80 infections, with the source being a drug-resistant bacterium called Pseudomonas aeruginosa. Those recalls did not specifically target Visine, but they apply to the category you should be paying attention to.
What to do right now
If you have Visine at home, check the FDA's current recall list at FDA.gov to confirm your specific lot is not affected. Stop using any affected drops immediately, throw the bottle away or return it to the retailer, and contact an eye doctor if you experience any pain, redness, or vision changes. For redness relief specifically, some eye care clinics now point patients toward Lumify, which uses a different mechanism and has a cleaner safety profile in their view.
Follow-ups
What is the sentiment on Ronto?
The sentiment on Rohto Dry eye drops is genuinely split: fans love the dramatic cooling sensation and fast redness relief, but eye care professionals have the same Visine red flag. Rohto redness-relief formulas include naphazoline hydrochloride; a tetrahydrozoline family vasoconstrictor known to slow heart rate.
What people love about it
Rohto Dry is a Japanese eye care brand sold widely in the US. Its signature is CoolSense Technology, a menthol-driven cooling sensation that hits the moment the drop lands. For many users that feeling IS the product: it wakes up tired eyes fast and the redness relief is real and quick. Fans tend to be loyal.
Where the concern lands
The mechanism is the problem, and it is the same one we covered with Visine. Most Rohto redness-relief products use naphazoline hydrochloride as their active ingredient, a decongestant that constricts the tiny blood vessels in your eyes, making redness disappear quickly. The biggest concern is rebound redness: when the vasoconstrictor wears off, your blood vessels dilate again, often more than before you used the drops.
Research shows this rebound effect can develop after as few as 5 to 10 days of repeated daily use, and in documented cases patients developed persistent redness after using naphazoline continuously for days to months. The American Academy of Ophthalmology warns that rebound redness "can worsen over time, leading to persistent red eyes."
This is not unique to Rohto. Visine, Clear Eyes, and any other drop containing naphazoline or tetrahydrozoline carry the same risk. The problem is the ingredient category, not the brand.
The one Rohto line that is different
Rohto also makes lubricant-only products, like Rohto Dry-Aid, that skip the vasoconstrictor entirely. These are a different category and don't carry the same risks. If you're shopping for Rohto drops, the distinction between their redness-relief formulas and their lubricating formulas matters more than the brand name itself.
The short version
Occasional use of the redness-relief formula is not going to hurt most people. Prolonged use can create a dependency cycle where your eyes become increasingly red and irritated when the drops are not used. Eye care professionals consistently recommend plain lubricating artificial tears for regular use, and Rohto's own lubricating line fits that bill. The cooling redness-relief drops are best treated as an occasional thing, not a daily habit.
Build something real while you still have momentum.
Mary posts daily on CEEK, and a growing community of creators and builders is already there working out their next move.
Join me on CEEK
Comments